Thymoma resection may reduce immune attack on the bone marrow and create conditions favorable for hematopoietic recovery by removing the source of continued generation and export of abnormal T cells; however, abnormal T cells that have already entered the peripheral blood or bone marrow and continue to survive may perpetuate immune-mediated injury.
Abstract
We report a case of recurrent type A thymoma accompanied by pure red cell aplasia (PRCA) and agranulocytosis. Following local recurrence after thymoma resection, the patient gradually developed anemia and leukopenia as the lesion progressed; bone marrow examination showed marked suppression of erythropoiesis and reduced granulopoiesis. Taken together with the peripheral blood findings, these results suggested thymoma-associated immune-mediated hematopoietic injury. Following multidisciplinary evaluation, the patient underwent thoracoscopic resection of the recurrent lesion, and pathological examination confirmed type A thymoma with negative surgical margins. Postoperative follow-up showed gradual recovery of erythropoiesis and achievement of transfusion independence, whereas agranulocytosis persisted; only after regular cyclosporine A treatment and increased drug exposure did the white blood cell and neutrophil counts gradually rise. Based on this case and previous studies, thymoma resection may reduce immune attack on the bone marrow and create conditions favorable for hematopoietic recovery by removing the source of continued generation and export of abnormal T cells; however, abnormal T cells that have already entered the peripheral blood or bone marrow and continue to survive may perpetuate immune-mediated injury. Therefore, blood counts should be monitored serially after surgery, and standardized adjunctive immunosuppressive therapy should be instituted when necessary. During treatment, close attention should also be paid to medication adherence, therapeutic drug concentrations, and monitoring of hepatic and renal function to balance efficacy and safety.
Background. Fibroblastic reticular cell tumor (FRCT) is an extremly rare neoplasm arising from stromal cells of lymphoid tissues, characterized by aggressive biological behavior and significant diagnostic challenges. Due to its rarity, the current literature is limited to a small number of case reports, underscoring th...
E. Cosi· Bleeding Thrombosis and Vasc...· 0 citations
We report the case of a 69-year-old woman with metastatic lung adenocarcinoma who developed severe thrombotic microangiopathy (TMA) only seven days after receiving her first dose of gemcitabine. The patient had pre-existing stage 3a chronic kidney disease and previous exposure to bevacizumab, which may have increased h...
S. Badaoui, M. Bouchoual, S. Anibar et al.· SAS Journal of Medicine· 0 citations
Allogeneic hematopoietic stem cell transplantation may provide effective disease control in refractory cases and VEXAS syndrome should be considered in young adults presenting with unexplained systemic inflammation and cytopenias, even with atypical manifestations such as orbital cellulitis.
Gokhan Burul, C. Karaoglan, E. Bektaş et al.· Journal of Hematopathology· 1 citation
Abstract Introduction: Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue tumor of low malignant potential, and its radiological appearance is often non-specific, mimicking benign cysts, hematomas, or infections, necessitating histopathological and immunohistochemical confirmation. While hematological maligna...
Sandeep Sehrawat, V. Kumar, L. Kapoor et al.· Journal of Orthopaedic Case...· 0 citations
Leukemia cutis (LC) is a rare extramedullary manifestation of leukemia resulting from infiltration of leukemic cells into the skin. Although uncommon in children, LC may represent the initial manifestation of leukemia and can clinically and histopathologically mimic other malignancies, including Burkitt lymphoma, leadi...
H. Munaku, Ruchius Philbert, Lilian Bachuba et al.· Discover medicine· 0 citations
Hemophagocytic lymphohistiocytosis (HLH) is a severe, life-threatening hyperinflammatory syndrome characterized by dysregulated activation of cytotoxic T-lymphocytes and macrophages, with lymphoma-associated HLH (LA-HLH) carrying a particularly poor prognosis due to delayed diagnosis and lack of optimal treatment regim...